NasdaqCM - Nasdaq Real Time Price USD
Brainstorm Cell Therapeutics Inc. (BCLI)
0.8700
-0.0058
(-0.66%)
At close: April 23 at 4:00:00 PM EDT
0.9116
+0.04
+(4.89%)
Pre-Market: 4:11:35 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.27M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FRENKEL JACOB A. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| HARTOUNIAN HARTOUN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| ARBEL IRIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| YABLONKA URI Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| PATLIS ALLA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| POLVERINO ANTHONY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| LINDBORG STACY R. PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| BAIRU MENGHISTEAB M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| NAOR NIR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| DAGHER IBRAHIM B. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Purchase at price 0.22 - 0.23 per share. | Direct | 5,414 | Oct 1, 2024 |
| DAGHER IBRAHIM B. Officer | Sale at price 0.35 per share. | Direct | 22,069 | Jul 19, 2024 |
| HARTOUNIAN HARTOUN Chief Operating Officer | -- | Direct | -- | Jun 24, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.52 per share. | Direct | 7,774 | May 28, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Purchase at price 0.52 per share. | Direct | 7,774 | May 28, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.58 - 0.64 per share. | Direct | 30,475 | May 22, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Purchase at price 0.58 - 0.64 per share. | Direct | 30,475 | May 22, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.46 - 0.49 per share. | Direct | 18,865 | May 13, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Purchase at price 0.46 - 0.49 per share. | Direct | 18,865 | May 13, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.37 per share. | Direct | 24,816 | May 7, 2024 |
| LEBOVITS CHAIM Officer | Purchase at price 0.37 per share. | Direct | 24,816 | May 7, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.38 per share. | Direct | 50,666 | May 6, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Purchase at price 0.38 per share. | Direct | 50,666 | May 6, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.52 per share. | Direct | 7,798 | Apr 19, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Purchase at price 0.52 per share. | Direct | 7,798 | Apr 19, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.53 - 0.55 per share. | Direct | 131,411 | Apr 18, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | Purchase at price 0.53 - 0.55 per share. | Direct | 131,411 | Apr 18, 2024 |
| LEBOVITS CHAIM Chief Executive Officer | -- | Direct | -- | Mar 11, 2024 |
| YABLONKA URI Officer and Director | -- | Direct | -- | Mar 11, 2024 |
| PATLIS ALLA Chief Financial Officer | -- | Direct | -- | Mar 11, 2024 |
| LINDBORG STACY R. PH.D. Chief Executive Officer | -- | Direct | -- | Mar 11, 2024 |
| LINDBORG STACY R. PH.D. Chief Executive Officer | Purchase at price 1.77 per share. | Direct | 20,402 | Sep 1, 2023 |
| LEBOVITS CHAIM Chief Executive Officer | -- | Direct | -- | Aug 2, 2023 |
| LINDBORG STACY R. PH.D. Chief Executive Officer | -- | Direct | -- | Aug 2, 2023 |
| NAOR NIR Director | -- | Direct | -- | Jun 16, 2023 |
| TAYLOR KIRK Officer | -- | Direct | -- | May 1, 2023 |
Related Tickers
BLRX BioLineRx Ltd.
3.0000
+3.45%
PLUR Pluri Inc.
6.75
+40.62%
SVRA Savara Inc.
3.2500
+0.93%
VYGR Voyager Therapeutics, Inc.
3.4900
+3.56%
CERO CERo Therapeutics Holdings, Inc.
0.7994
+5.49%
MTVA MetaVia Inc.
0.8130
+8.40%
GUTS Fractyl Health, Inc.
1.3300
+3.91%
VRPX Virpax Pharmaceuticals, Inc.
0.2600
+10.64%
PPBT Purple Biotech Ltd
2.6724
-4.90%
ENLV.TA Enlivex Therapeutics Ltd.
335.40
+1.45%